HIGHLIGHTS
- who: Fabiana Furci and colleagues from the Allergy Unit and Asthma Center, Verona University Hospital, Verona, Italy have published the research work: TSLP and HMGB1: Inflammatory Targets and Potential Biomarkers for Precision Medicine in Asthma and COPD, in the Journal: Biomedicines 2023, 11, 437. of /2023/
- what: The authors aim to analyze the role of alarmins, in particular of HMGB1 and TSLP, in asthma and COPD, identifying similarities and differences which may be useful for therapeutic approaches that are as targeted as possible.
- how: This result was confirmed by other studies such as . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.